Search

everythinglearnresearchcommunity

for

Search:↓

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

PRP hair treatment is generally safe but may cause minor pain, bleeding, redness, and scalp tightness, and isn't suitable for everyone.

Mild oxidative stress can prevent hair loss from chemotherapy.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Exosome treatment for hair growth is promising but not FDA-approved and needs more research on safety and how it works.

Finasteride effectively treats male hair loss, increasing length and thickness.

Blocking a compound called prostaglandin D₂ might help treat hair loss.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Ferulic acid helps stabilize vitamins C and E for better skin protection from the sun, certain compounds may promote hair growth, atopic dermatitis patients have lower skin defense molecules, older men are more likely to get a type of skin cancer, and a substance called relaxin may prevent age-related skin thickening.

Hinokiflavone may help treat cancers and other health issues.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Vijaya successfully fought stage 2A breast cancer with surgery, chemotherapy, radiotherapy, and hormone therapy, while advocating for support groups.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.